elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36236997-B4DA1F15-E7C2-4F22-85B9-06AE2E7F057D
Q36236997-B4DA1F15-E7C2-4F22-85B9-06AE2E7F057D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36236997-B4DA1F15-E7C2-4F22-85B9-06AE2E7F057D
Extracting the Benefit of Nexrutine® for Cancer Prevention.
P2860
Q36236997-B4DA1F15-E7C2-4F22-85B9-06AE2E7F057D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36236997-B4DA1F15-E7C2-4F22-85B9-06AE2E7F057D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e7ce95a03f13876b7da6b28a5bea91e1fa9a585
P2860
Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract